FKBP14
protein-codingFKBP prolyl isomerase 14, the group of FKBP prolyl isomerases|EF-hand domain containing
Gene summary
The protein encoded by this gene is a member of the FK506-binding protein family of peptidyl-prolyl cis-trans isomerases. The encoded protein is found in the lumen of the endoplasmic reticulum, where it is thought to accelerate protein folding. Defects in this gene are a cause of a type of Ehlers-Danlos syndrome (EDS). Both a protein-coding variant and noncoding variants are transcribed from this gene. [provided by RefSeq, Mar 2012]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~16.1 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0013800
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0013800
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0013800
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0013800
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0013800
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0013800
Submitter: Genomics England PanelApp
Clinical Genomic Database (CGD)
Manifestation: Audiologic/Otolaryngologic; Cardiovascular; Craniofacial; Genitourinary; Dermatologic; Musculoskeletal; Neurologic; Ophthalmologic
Intervention: Cardiovascular
Rationale: Cardiovascular complications, including aortic rupture, have been described, and awareness and surveillance may allow rapid diagnosis and treatment, which may ameliorate morbidity and mortality
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to FKBP14 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_017946.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 65 | 2 | 67 | |||
| missense | 130 | 7 | 137 | |||
| nonsense | 3 | 1 | 2 | 6 | ||
| start loss | 0 | |||||
| frameshift | 6 | 7 | 1 | 14 | ||
| splice donor/acceptor (+/-2bp) | 3 | 4 | 7 | |||
| Total | 9 | 11 | 137 | 72 | 2 | 231 |
Highest pathogenic variant AF is 0.0007022668
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_060416.1 | 4 | MANE Select | |
| Ensembl | ENSP00000222803.5 | 4 | MANE Select | |
| Ensembl | ENSP00000403279.1 | 3 | Standard | |
| Ensembl | ENSP00000406270.1 | 2 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- XBP1(S) activates chaperone genes
Biological Process
- protein peptidyl-prolyl isomerization
- IRE1-mediated unfolded protein response
Molecular Function
- peptidyl-prolyl cis-trans isomerase activity
- calcium ion binding
Cellular Component
- endoplasmic reticulum lumen
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000222803
- Coding exons
- 4
- Length
- 16098
- Individuals with no LoFs
- 125605
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 143
- Defined
- 125748
- p
- 0.000569
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.0939 | 105 | 108 | 0.975 | 0.00000479 | 1404 |
| Missense (PolyPhen) | 40 | 46.869 | 0.85344 | 607 | ||
| Synonymous | 0.782 | 33 | 39.2 | 0.841 | 0.00000189 | 371 |
| Loss of Function | 0.0702 | 9 | 9.23 | 0.975 | 4.60e-7 | 122 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00013 | 0.00012 | rare |
| Latino/Admixed American | 0.00042 | 0.00032 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.00016 | 0.00016 | rare |
| Finnish | 0.00029 | 0.00028 | rare |
| European (Non-Finnish) | 0.0011 | 0.00098 | notable |
| South Asian | 0.00024 | 0.00023 | rare |
| Other | 0.00041 | 0.00033 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: PPIase which accelerates the folding of proteins during protein synthesis. Has a preference for substrates containing 4- hydroxylproline modifications, including type III collagen. May also target type VI and type X collagens. {ECO:0000269|PubMed:24821723}.;
- Disease
- DISEASE: Ehlers-Danlos syndrome, kyphoscoliotic type, 2 (EDSKSCL2) [MIM:614557]: A form of Ehlers-Danlos syndrome, a group of connective tissue disorders characterized by skin hyperextensibility, articular hypermobility, and tissue fragility. EDSKSCL2 is an autosomal recessive form characterized by severe generalized hypotonia at birth, myopathy, early-onset progressive kyphoscoliosis, joint hypermobility without contractures, hyperelastic skin with follicular hyperkeratosis, easy bruising, and occasional abnormal scarring, sensorineural hearing impairment, and normal pyridinoline excretion in urine. {ECO:0000269|PubMed:22265013}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.116
Intolerance Scores
- LoFtool
- 0.751
- RVIS EVS
- -0.16
- RVIS percentile EVS
- 41.64
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.949
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |